Well, a lot of these ANALysts have missed the boat and now trying to get back on this runaway train. Too bad.
Thanks Tartia. Hope you are right. Of course you carefully worded it as 24-30 month period:) No way to know anything before that? Right now the only action around SPPI seems to be from these ambulance chasers. Depressing!
I don't think it will come down. JNJ was stuck too long in a rut. But not any more.
Did anybody see Gorsky being interviewed by Ms.. Bartiromo on CNBC? Gorsky sizzles! Attaboy!
It is good to put things in perspective. This is a classic pattern. JNJ was languishing in the 70's and took off in early 80's. It was languishing a bit again in late 80's and took off again in mid 90's along with other pharmas. It was languishing long enough to be ignored by the market completely in 2000's and now boom time again. Also from a fundamental point of view J&J pipeline has become very strong and it is firing on all cylinders. So this has a lot of room to run for a few more years. Sorry nay-sayers, time to get on board.
That's a lot of If's. Looks like it is going to be a while to get answers to these questions. And the company has pretty much clammed up -- possibly because of the law suits. I bet Raj is laying low waiting for the dust to settle. I wish he would do the right thing.
IMHO, this has a lot of room to run. I think we are seeing late 90's once again when pharmas were surging fast and splitting every other year.
A win-win game is for him is to just concede and take the Chief Scientist spot and give the reins to mr. Keller. What he is doing now is the classic "denial" -- the longer he does it, the worse it will be for everyone. I hope he wakes up and not keeps playing the fiddle while Rome is burning.
Yep. When pfizer starts moving, you better get outs way.. it is a runaway train. Remember the 95-99 period. Actually, I expect a double from here in 18 months.
May be he didn't want to rock the boat as soon as he came on board. May be he had some closed door arguments with Raj that led nowhere. Thing is this company has to act quickly, make some important decisions, and move things along. We need some good news, else hope can give into despair and the pps can erode steadily. Keller needs to know and be convinced that he is the future of comapany. Raj needs to act in the interest of the shareholders. May be, finding a buyer is the best path forward. At least, not all value will be lost then.
Candide and others who have listened to the conference call --- was there any suggestion or expectation as to what effect all this investment in sales force (including the addition of Keller) has had or will have on the sales? After all Keller came on board ony about 6 (?) months ago. It takes time to make an impact. What surprised me was they seemed to have brought down their expectations drastically without accounting for any of that. Was there any hint of a moderating influence rom the sales force? (Also, I hope they have a reimbursement group that is working on improving access to various customers including hospitals.)
Both of you are making good points. J&J will maintain its record of a steady predictable increase in dividend -- let us say 4 to 5 cents (or may be 6). The point is, when the stock gets back on its growth path, the yield will come back to more normal historic levels -- 2 to 2.5%
Nice to see your post Pcka! Do you think the news is already baked into the price or there is more room to run? It is interesting that this drug has been approved just when another major JNJ (and Amgen) drug EPO goes off patent.
Yes. They should be doing a lot of things -- and they are not doing it. I say, they should put up the company for sale. Let us salvage some value while it is not too late. Well, may be it is too late. With all these law suits and what not, would anyone be willing to buy this company? Oh, what a mess! Raj, act quickly.